BeOne Secures $885 Million in Royalty Deal with Amgen
BeOne Medicines has signed a significant royalty agreement with Amgen, securing an upfront payment of $885 million. This deal positions BeOne, formerly known as BeiGene, as a prominent player in…
Breaking News & Top Stories
BeOne Medicines has signed a significant royalty agreement with Amgen, securing an upfront payment of $885 million. This deal positions BeOne, formerly known as BeiGene, as a prominent player in…